Patent AnalyticsExaminers
Menu

Application

18000141 · MULTISPECIFIC ANTIBODY COMPRISING TWO ANTIBODY-BASED BINDING DOMAINS, WHICH SPECIFICALLY BIND TO MESOTHELIN (MSLN-BD); AND ONE ANTIBODY-BASED BINDING DOMAIN, WHICH SPECIFICALLY BINDS TO CD3 (CD3-BD)

Filed 2022-11-29 · Granted The official file ↗ · Art unit 1641 · Examiner Michael Edward Szperka Typical · CPC C07K 16/2809 · Numab Therapeutics AG · Prismatic Law Group, PLLC

Office actions
2
first was Non-final rejection
RCEs
0
no appeal
To first action
33.7 mo
to disposition 45.8 mo
Statutes raised
103 112
2 actions read
Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in